Pharmaceuticals in South Africa

Date: September 26, 2016
Pages: 39
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PB5F41FBE88EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in South Africa
SUMMARY

Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Africa
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Africa
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the South Africa pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the South Africa pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the South Africa pharmaceuticals market by value in 2015?
  • What will be the size of the South Africa pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the South Africa pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in South Africa's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The South African pharmaceuticals market had total revenues of $2.9bn in 2015, representing a compound annual growth rate (CAGR) of 0.1% between 2011 and 2015.

South Africa has a large manufacturing base in the country with both large foreign players and domestic players alike. One domestic player, Aspen, healthcare has been granted multiple licenses to produce a large amount of generics in the country and this may be having the effect of slowing down the market somewhat as revenues from expensive patented drugs are replaced with cheaper alternatives.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 6% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $3.9bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Adcock Ingram Holdings Limited
Aspen Pharmacare Holdings Ltd
Novartis AG
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: South Africa pharmaceuticals market value: $ billion, 2011-15
Table 2: South Africa pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: South Africa pharmaceuticals market share: % share, by value, 2015
Table 4: South Africa pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Adcock Ingram Holdings Limited: key facts
Table 6: Adcock Ingram Holdings Limited: key financials ($)
Table 7: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 8: Adcock Ingram Holdings Limited: key financial ratios
Table 9: Aspen Pharmacare Holdings Ltd: key facts
Table 10: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 11: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 12: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: Sanofi SA: key facts
Table 17: Sanofi SA: key financials ($)
Table 18: Sanofi SA: key financials (€)
Table 19: Sanofi SA: key financial ratios
Table 20: South Africa size of population (million), 2011-15
Table 21: South Africa gdp (constant 2005 prices, $ billion), 2011-15
Table 22: South Africa gdp (current prices, $ billion), 2011-15
Table 23: South Africa inflation, 2011-15
Table 24: South Africa consumer price index (absolute), 2011-15
Table 25: South Africa exchange rate, 2011-15

LIST OF FIGURES

Figure 1: South Africa pharmaceuticals market value: $ billion, 2011-15
Figure 2: South Africa pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: South Africa pharmaceuticals market share: % share, by value, 2015
Figure 4: South Africa pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in South Africa, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Africa, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Africa, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2015
Figure 11: Adcock Ingram Holdings Limited: revenues and profitability
Figure 12: Adcock Ingram Holdings Limited: assets and liabilities
Figure 13: Aspen Pharmacare Holdings Ltd: revenues and profitability
Figure 14: Aspen Pharmacare Holdings Ltd: assets and liabilities
Figure 15: Novartis AG: revenues and profitability
Figure 16: Novartis AG: assets and liabilities
Figure 17: Sanofi SA: revenues and profitability
Figure 18: Sanofi SA: assets and liabilities

COMPANIES MENTIONED

Adcock Ingram Holdings Limited
Aspen Pharmacare Holdings Ltd
Novartis AG
Sanofi SA
Skip to top


Ask Your Question

Pharmaceuticals in South Africa
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: